As of 2025-05-16, the EV/EBITDA ratio of NLS Pharmaceutics AG (NLSP) is -. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NLSP's latest enterprise value is 5.16 mil USD. NLSP's TTM EBITDA according to its financial statements is - mil USD. Dividing these 2 quantities gives us the above NLSP EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative Enterprise Value.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |